These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23357814)

  • 1. Effects of squalene/squalane on dopamine levels, antioxidant enzyme activity, and fatty acid composition in the striatum of Parkinson's disease mouse model.
    Kabuto H; Yamanushi TT; Janjua N; Takayama F; Mankura M
    J Oleo Sci; 2013; 62(1):21-8. PubMed ID: 23357814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eugenol [2-methoxy-4-(2-propenyl)phenol] prevents 6-hydroxydopamine-induced dopamine depression and lipid peroxidation inductivity in mouse striatum.
    Kabuto H; Tada M; Kohno M
    Biol Pharm Bull; 2007 Mar; 30(3):423-7. PubMed ID: 17329831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] and eugenol [2-methoxy-4-(2-propenyl)phenol] on the pathological progress in the 6-hydroxydopamine-induced Parkinson's disease mouse model.
    Kabuto H; Yamanushi TT
    Neurochem Res; 2011 Dec; 36(12):2244-9. PubMed ID: 21769642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EPC-K1, a hydroxyl radical scavenger, prevents 6-hydroxydopamine-induced dopamine depletion in the mouse striatum by up-regulation of catalase activity.
    Kabuto H; Yokoi I; Iwata-Ichikawa E; Ogawa N
    Neurochem Res; 1999 Dec; 24(12):1543-8. PubMed ID: 10591404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] prevents 6-hydroxydopamine-induced dopamine depression in mouse striatum and increases superoxide scavenging activity in serum.
    Kabuto H; Nishizawa M; Tada M; Higashio C; Shishibori T; Kohno M
    Neurochem Res; 2005 Mar; 30(3):325-32. PubMed ID: 16018576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress mediated neuronal damage in the corpus striatum of 6-hydroxydopamine lesioned Parkinson's rats: neuroprotection by serotonin, GABA and bone marrow cells supplementation.
    Kuruvilla KP; Nandhu MS; Paul J; Paulose CS
    J Neurol Sci; 2013 Aug; 331(1-2):31-7. PubMed ID: 23726276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist.
    Iida M; Miyazaki I; Tanaka K; Kabuto H; Iwata-Ichikawa E; Ogawa N
    Brain Res; 1999 Aug; 838(1-2):51-9. PubMed ID: 10446316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies.
    Ahmad M; Yousuf S; Khan MB; Hoda MN; Ahmad AS; Ansari MA; Ishrat T; Agrawal AK; Islam F
    Pharmacol Biochem Behav; 2006 Jan; 83(1):150-60. PubMed ID: 16500697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of 6-hydroxydopamine-induced caspase activations due to increases in oxidative stress in the mouse striatum.
    Tanaka K; Ogawa N; Asanuma M
    Neurosci Lett; 2006 Dec; 410(2):85-9. PubMed ID: 17092650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of hesperidin in a model of Parkinson's disease induced by 6-hydroxydopamine in aged mice.
    Antunes MS; Goes AT; Boeira SP; Prigol M; Jesse CR
    Nutrition; 2014; 30(11-12):1415-22. PubMed ID: 25280422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docosahexaenoic acid ethyl ester enhances 6-hydroxydopamine-induced neuronal damage by induction of lipid peroxidation in mouse striatum.
    Kabuto H; Amakawa M; Mankura M; Yamanushi TT; Mori A
    Neurochem Res; 2009 Jul; 34(7):1299-303. PubMed ID: 19219632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
    Khan MM; Ahmad A; Ishrat T; Khan MB; Hoda MN; Khuwaja G; Raza SS; Khan A; Javed H; Vaibhav K; Islam F
    Brain Res; 2010 Apr; 1328():139-51. PubMed ID: 20167206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
    Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
    Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotection by crocetin in a hemi-parkinsonian rat model.
    Ahmad AS; Ansari MA; Ahmad M; Saleem S; Yousuf S; Hoda MN; Islam F
    Pharmacol Biochem Behav; 2005 Aug; 81(4):805-13. PubMed ID: 16005057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPI1046 prevents dopaminergic dysfunction by activating glutathione system in the mouse striatum.
    Tanaka K; Yoshioka M; Miyazaki I; Fujita N; Ogawa N
    Neurosci Lett; 2002 Mar; 321(1-2):45-8. PubMed ID: 11872253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dopamine agonist cabergoline provides neuroprotection by activation of the glutathione system and scavenging free radicals.
    Yoshioka M; Tanaka Ki; Miyazaki I; Fujita N; Higashi Y; Asanuma M; Ogawa N
    Neurosci Res; 2002 Jul; 43(3):259-67. PubMed ID: 12103444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in lipid peroxidation, Cu/Zn-superoxide dismutase and its mRNA following an intracerebroventricular injection of 6-hydroxydopamine in mice.
    Ogawa N; Asanuma M; Kondo Y; Hirata H; Nishibayashi S; Mori A
    Brain Res; 1994 May; 646(2):337-40. PubMed ID: 8069686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway.
    Guo S; Yan J; Yang T; Yang X; Bezard E; Zhao B
    Biol Psychiatry; 2007 Dec; 62(12):1353-62. PubMed ID: 17624318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of swimming training in a mouse model of Parkinson's disease induced by 6-hydroxydopamine.
    Goes AT; Souza LC; Filho CB; Del Fabbro L; De Gomes MG; Boeira SP; Jesse CR
    Neuroscience; 2014 Jan; 256():61-71. PubMed ID: 24090962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status of antioxidant defense system and expression of toxicant responsive genes in striatum of maneb- and paraquat-induced Parkinson's disease phenotype in mouse: mechanism of neurodegeneration.
    Patel S; Singh V; Kumar A; Gupta YK; Singh MP
    Brain Res; 2006 Apr; 1081(1):9-18. PubMed ID: 16510128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.